Genomic Valley Biotech informs about quarterly statement on investor complaints

18 Jul 2016 Evaluate

Genomic Valley Biotech has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

29.00 0.00 (0.00%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1284.45
Mangalam Global Ent 9.99
Kaveri Seed 749.65
Regaal Resources 64.74
Simran Farms 153.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×